Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis

doi:10.3748/wjg.v19.i29.4679

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 29

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6090)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

479

HTML

3511

Figures (1-4)

182

Tables (1-6)

199

Sum=4371

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

912

Download

807

Sum=1719

Aug 7, 2013 (publication date) through Aug 24, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Aug 7, 2013; 19(29): 4679-4688
Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4679

Table 1 Baseline patient characteristics

Patient characteristics	Statistic
Age (yr)	54 (37-74)
Gender (male/female)	39/11
Etiology
HBV/HCV/non-viral	39/6/5
Child-Pugh classification
A5/A6/B7	17/25/8
Staging
BCLC staging C	50
Modified UICC (III/IVa/IVb)	9/31/10
Tumor type
Nodular/massive/infiltrative	3/4/43
Portal vein thrombosis
Vp2/Vp3/Vp4	7/13/30
Maximal tumor size (cm)
< 10/≥ 10	26/24
Tumor volume (cm³)¹	492.7 (26.1-2746.6)
Extrahepatic metastases	16
Previous treatment
TACL/TACL + RFA/TACL + ERT	19/3/2
Total bilirubin (mg/dL)¹	0.87 (0.34-1.99)
PT (INR)¹	1.14 (0.94-1.38)
ALT (IU/L)¹	37 (15-345)
Platelet count (× 10³/mL)¹	133 (50-326)
AFP (ng/mL)¹	3084.15 (7.94-426100)
PIVKA-II (mAU/mL)¹	1190 (16-12000)

¹Expressed as the median (range). AFP: Alpha-fetoprotein; AJCC: American Joint Committee on Cancer; ALT: Alanine aminotransferase; BCLC: Barcelona Clinic Liver Cancer; ERT: External radiation therapy; HBV: Hepatitis B virus; HCV: Hepatitis C virus; PIVKA: Protein induced by vitamin K absence or antagonist; PT: Prothrombin time; RFA: Radiofrequency ablation; TACL: Transarterial chemolipiodolization; UICC: Union for International Cancer Control.

Citation: Song DS, Bae SH, Song MJ, Lee SW, Kim HY, Lee YJ, Oh JS, Chun HJ, Lee HG, Choi JY, Yoon SK. Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2013; 19(29): 4679-4688
URL: https://www.wjgnet.com/1007-9327/full/v19/i29/4679.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i29.4679